Re-diethylenetriamine pentaacetic acid-glucosamine

Subscribe to Selected New Research on Re-diethylenetriamine pentaacetic acid-glucosamine

1 relevant articles (1 outcomes, 1 trials/studies) found for this Bio-Agent

Description: has a significant apoptotic effect on carcinoma cells

Also Known As:

188Re-DTPA-DG

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Organometallic Compounds: 5

Re-diethylenetriamine pentaacetic acid-glucosamine: 1

Experts

1.	Xiong, Qing-Feng: 1 article (08/2007)
2.	Chen, Yue: 1 article (08/2007)
3.	Li, Ju-Lian: 1 article (08/2007)
4.	Deng, Cun-Liang: 1 article (08/2007)
5.	He, Ling: 1 article (08/2007)
6.	Huang, Zhan-Wen: 1 article (08/2007)

Related Diseases

1.	Neoplasms (Cancer) 08/01/2007 - "The biodistribution study in tumor-bearing nude mice showed that the concentration of 188Re-DTPA-DG in tumor tissue was much higher than in normal tissue, that 188Re-DTPA-DG was rapidly cleared from the blood, and that the main route of its clearance was via the kidneys" 08/01/2007 - "In order to determine the affinity of 188Re-DTPA-DG for tumor tissue, the biodistribution of the radiolabeled agent was assessed in breast tumor-bearing nude mice" Get all the results and reference details, order at left...
2.	Carcinoma (Carcinomatosis) 08/01/2007 - "Study of apoptosis induced by 188Re-DTPA-DG in MCF-7 breast carcinoma and A549 pulmonary carcinoma cells." 08/01/2007 - "CONCLUSIONS: 188Re-DTPA-DG has a significant apoptotic effect on carcinoma cells" Get all the results and reference details, order at left...
3.	Breast Neoplasms (Breast Cancer) 08/01/2007 - "In order to determine the affinity of 188Re-DTPA-DG for tumor tissue, the biodistribution of the radiolabeled agent was assessed in breast tumor-bearing nude mice" Get all the results and reference details, order at left...
3 Diseases and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>